SCHEMBL9004607

SCHEMBL9004607

CSNC(=O)NN=c1c(=O)c2ccccc2c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
SENP6 Q9GZR1 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
CASP3 P42574 2/20 0.55
SENP8 Q96LD8 2/20 0.55
SENP7 Q9BQF6 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 2/20 0.55
APAF1 O14727 1/20 0.55
TDP2 O95551 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
THRB P10828 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004657 0.83 MAPT (0.51) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL9004689 0.81 MAPT (0.56) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL9004601 0.77 SMN1; SMN2 (0.48) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL9004660 0.77 SMN1; SMN2 (0.51) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL9004711 0.77 SMN1; SMN2 (0.48) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL8667830 0.75 SENP6 (0.61) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL8856519 0.75 SENP6 (0.61) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL9004597 0.74 MAPT (0.64) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL9004650 0.74 MAPT (0.51) MAPTSENP6SMN1; SMN2CASP3SENP8
SCHEMBL9004678 0.74 SMN1; SMN2 (0.51) MAPTSENP6SMN1; SMN2CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571843-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1996-11-05 US disclosed
EP-0566445-B1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566445-A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020045-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR THE PREPARATION OF SAME AND THEIR APPLICATION AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed